GMRE-PA - Global Medical R... Stock Analysis | Stock Taper
Logo
Global Medical REIT Inc.

GMRE-PA

Global Medical REIT Inc. NYSE
$24.63 -1.04% (-0.26)

Market Cap $398.01 M
52w High $25.57
52w Low $23.38
Dividend Yield 7.80%
Frequency Quarterly
P/E 123.77
Volume 1.27K
Outstanding Shares 16.16M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $35.17M $38.39M $-11.78M -33.5% $-0.55 $984K
Q3-2025 $40.56M $4.86M $-4.55M -11.21% $-0.45 $9.95M
Q2-2025 $37.88M $21.32M $655K 1.73% $-0.3 $23.89M
Q1-2025 $34.59M $17.45M $3.56M 10.29% $0.79 $24.95M
Q4-2024 $34.95M $21.35M $2.83M 8.1% $0.52 $24.4M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $9.08M $1.24B $712.4M $509.77M
Q3-2025 $7.12M $1.27B $767.41M $485.29M
Q2-2025 $6.58M $1.3B $771.94M $503.2M
Q1-2025 $5.41M $1.27B $731.45M $517.35M
Q4-2024 $6.82M $1.26B $700.57M $534.13M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $-5.06M $17.57M $-703K $-16.25M $614K $92.61M
Q2-2025 $585K $22.14M $-39.23M $18.72M $1.64M $-18.32M
Q1-2025 $3.56M $12.27M $-27.22M $13.6M $-1.35M $-22.32M
Q4-2024 $2.94M $20.52M $-19.52M $153K $1.15M $-33.34M
Q3-2024 $3.2M $16.3M $-25.49M $9.16M $-29K $21.51M

What's strong about this company's cash flow?

The company turned things around with a big jump in free cash flow and paid down debt instead of borrowing more. Dividends are well covered by cash generation, and there’s no dilution from new shares.

What are the cash flow concerns?

Operating cash flow dropped compared to last quarter, and the cash balance is still modest. The business is capital intensive, and a big part of reported losses are non-cash, which could hide underlying issues.

Q3 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Global Medical REIT Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Key positives include a sizable healthcare real estate portfolio that generates strong operating cash, an apparent balance sheet with low current leverage and adequate liquidity, and a focused strategy built around mission‑critical healthcare properties under triple‑net leases. The company’s specialization in secondary and suburban markets, combined with careful underwriting and strong tenant relationships, provides a differentiated competitive position. Its ability to re‑lease properties after tenant stress and maintain high occupancy supports the view that its assets are generally well‑located and in demand.

! Risks

Major risks center on profitability and capital dependence: the business is currently loss-making on an accounting basis, carries negative retained earnings, and posts negative free cash flow after heavy investment spending and dividends. Historical interest expense indicates that leverage has been an important part of the model, even if period-end debt balances now look low. Unusual reporting items—such as zero current liabilities and zero gross and operating profit—make it harder to assess true underlying economics. Beyond the numbers, the company faces sector-specific risks tied to healthcare tenant credit quality, regulatory changes, and sensitivity to interest rates and capital market conditions.

Outlook

Looking ahead, the company appears positioned as a niche healthcare REIT with a clear strategy and an asset base capable of generating solid operating cash, but with important questions around earnings quality, reliance on external capital, and the sustainability of its current growth and payout profile. The rebranding to Chiron Real Estate and new leadership suggest an intent to refine and possibly strengthen the business model, yet the benefits of this shift will only become clear over time. The future trajectory will depend on management’s ability to maintain high occupancy, improve economic profitability, execute disciplined capital allocation, and navigate the broader healthcare and interest rate environment without overextending the balance sheet.